 The investigators will therefore secondarily conduct an economic evaluation to determine the relative incremental hospital cost of each fluid. To the extent that one fluid or the other reduces cost assuming similar complication rates, the Clinic will be able to reduce cost by specifying the appropriate fluid without impairing quality. 